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ABSTRACT

JUSTIN B. DAVIS
Examining Disparities Related to the Use of Hospice Care: Cancer vs. Non-cancer
Diagnoses
(Under the direction of BRUCE C. PERRY, MD, MPH)
Americans often face end-of-life with ineffective pain/symptom control. While
hospice care prevents suffering for the terminally ill, only around 40% of individuals
access services. Although few studies describe differences in terms of cancer vs. noncancer diagnoses, hospice utilization/access disparities appear to exist. Analyzing 14
sociodemographic and clinical variables for 3,905 hospice discharge cases, this study
highlights observed disproportions between cancer and non-cancer groups, identifying
significant relationships amongst patient characteristics and hospice diagnosis. Factors
found significantly related to diagnosis include components of the following: age,
primary payment source, mortality status at discharge, hospice initiation location, length
of stay, physical function, cognitive function, and presence of pain symptoms. Results
confirm low overall hospice utilization rates, while validating diagnosis-specific
differences driven by individual and population-based characteristics. In order to
increase utilization/access rates and eliminate current disparities, patients presenting with
certain terminal diseases may require greater provider flexibility in terms of hospice
eligibility requirements.
INDEX WORDS: hospice care, palliative care, health disparities, cancer, chronic disease,
death and dying, end-of-life
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Chapter I
Introduction
1.1 Background
Over at least the past six decades, the world’s human population has significantly
transformed, experiencing record-breaking growth rates. In addition to birthrate
increases partially responsible for progress during the 20th century, the human lifespan
also continues to lengthen, further compounding the rise in population and leading to
momentous advances in aging (Schoeni & Ofstedal, 2010). Evidence of the aging
population includes not only longer life expectancies, but also the increase in the
proportion of the elderly in today’s society. Particularly, in the United States (U.S.), the
percentage of individuals aged 65 and older is expected to comprise 20% of the total
population by mid-21st century – a notable difference from roughly 4% in the early
1900’s (McLaughlin, Connell, Heeringa, Li, & Roberts, 2010).
Paralleled by the evolving aging structure in the U.S., the conditions associated
with living longer, along with the end-of-life experience, have also changed considerably
in the past 100 years. Due to advances in the fight against infectious disease, coupled
with lower mortality rates, aging Americans now suffer from mostly lingering chronic
conditions (Lehning & Austin, 2010). Consequently, ailments such as heart, pulmonary,
and cerebrovascular diseases currently prevail as leading causes of death (Mokdad,
Marks, Stroup, & Gerberding, 2004). Related primarily to the long-term nature of
chronic diseases and the uncertainty regarding the multiple paths of decline that often
lead to death, anticipating and approaching end-of-life issues and planning has
1
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become increasingly challenging (Batchelor, 2010). Certainly, Americans’ tendency to
avoid the topic of death also complicates the ability and willingness to address such
sensitive issues (Wasserman, 2008).
Although evidence-based models providing quality end-of-life care exist, a
shocking proportion of Americans currently face death in undesirable settings, increasing
their chances of experiencing inadequate pain and symptom control (Galanos, Morris,
Pieper, Poppe-Ries, & Steinhauser, 2012). Offering holistic care for those who are
terminally ill, hospice services are generally regarded as superior in promoting comfort
and quality of life; however, more than half of dying Americans lack the benefits that
hospice provides (“NHPCO Facts,” 2012). Furthermore, of those in the minority that do
access hospice care at the end-of-life, most are referred too late in the disease process, as
approximately 62% of hospice patients only receive 30 days or less of the potential 180+
days of care available (“NHPCO Facts,” 2012). While the U.S. significantly outspends
other developed nations in terms of medical advancement, unfortunately, most Americans
suffer at end-of-life with underfunded care and low quality-of-death ratings (Hoefler,
2010).
1.2 Purpose of Study
Although commonly indicated by public health efforts, the promotion of health
does not always involve prolonging life. According to the World Health Organization,
“Health is a state of complete physical, mental and social well-being and not merely the
absence of disease or infirmity” (“Preamble to the Constitution,” 1946). Fittingly, when
a disease process can no longer be prevented or reversed, well-being should translate to
the absence of pain and suffering and overall quality of life remaining. However,
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previous research has shown that the American health care system is flawed in regards to
the promotion of well-being at end-of-life (Bern-Klug, 2009; O’Mahony et al., 2008;
Resnick, Foster, & Hickman, 2009; Walling et al., 2010). While the hospice model of
care remains backed by a considerable evidence base regarding efficacy, particularly in
response to holistic well-being, a shocking majority of the U.S. population continues to
face death without its benefits (“NHPCO Facts,” 2012).
Attempting to pinpoint answers concerning low hospice enrollment rates,
numerous studies have indicated that significant disparities related to hospice access and
utilization exist (Carrion, Park, & Lee, 2011; duPreez et al., 2008; Givens, Tjia, Zhou,
Emanuel, & Ash, 2010; Silveira, Connor, Goold, McMahon, & Feudtner, 2011).
However, since hospice was originally introduced as care for terminally ill cancer
patients, much of the available research does not include cases with non-cancer diagnoses
(Cohen, 2008). Of the studies that do include the latter, most seem to focus on one
particular disease (duPreez et al., 2008; Givens et al., 2010). Consequently, relatively
few studies attempt to describe hospice use disparities between general cancer and noncancer diagnosis groups, which remains concerning given the fact that the majority of
hospice patients no longer suffer from cancer (“NHPCO Facts,” 2012). By further
expanding knowledge regarding hospice use disparities, a better understanding of
methods to reach greater proportions of the American population with critical end-of-life
services will emerge. Likewise, the emergence of new knowledge creates the potential to
improve care for those individuals who are already likely to access hospice services.
Therefore, the purpose of this study is to describe hospice use statistics from a nationally
representative sample of cancer and non-cancer hospice discharges, as well as explore the
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relationship between diagnosis and patient/population characteristics in an attempt to
illuminate factors that may play a role in imbalanced hospice utilization and access rates
in the U.S.
1.3 Research Questions
1. What are characteristics (sociodemographic and clinical) of a nationally
representative sample of hospice patients?
2. What are differences between patients with cancer vs. non-cancer hospice
diagnoses?
3. To what extent do patient/population characteristics (sociodemographic and
clinical) relate to hospice diagnosis?

	
  

	
  

Chapter II
Review of Literature
2.1 Aging
2.1.1 Aging Global Population
The 20th century brought about unprecedented growth in the world’s population.
In the 18 years after World War II alone, the baby boomer generation multiplied, creating
around 400 million new human lives (Olshansky, Goldman, Zheng, & Rowe, 2009).
While many factors contributed to the dramatic increase in population, rises in fertility
and improvements in mortality played large roles (Cherlin, 2010). In particular,
successes in infectious disease control and management of chronic disease have
significantly affected lifespan (Schoeni & Ofstedal, 2010). For example, those born in
2010 will live around 17 years longer than their elders of 50 years, enjoying an average
estimated lifespan of 69 years, worldwide (Schoeni & Ofstedal, 2010). The success of
aging is evident, especially when examining the world’s older population, aged 65 years
plus (65+). Between 2008 and 2040, it is estimated that this group will almost double in
size, from 7.8% to 14.7% of the total population, which will equal around 1.3 billion
older people by 2040 (Schoeni & Ofstedal, 2010). Additionally, the world’s oldest-old
population continues to increase. Growing more quickly than the 65+ age group, the
subset aged 80 plus (80+) is expected to represent 24% of the older population by 2040
(Schoeni & Ofstedal, 2010).

5
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2.1.2 Aging U.S. Population
Although developed countries are aging at slower rates than those in the
developing world, the U.S. continues to experience significant growth (Schoeni &
Ofstedal, 2010). As with the world population, the U.S. also benefits from both increased
longevity and decreased mortality. The Social Security Administration estimates that
overall morality will decline until 2032 by .86% per year (Olshansky et al., 2009). The
reduction in death rates leads to estimates of average life expectancy at birth ranging
from 80.9 to 85.9 years for males and 85.3 to 93.3 for females by the year 2050
(Olshansky et al., 2009). Combining the effects of increased life expectancy and
decreased mortality, there exists evidence that entire U.S. population will increase from
304.2 million in 2008 to between 410 and 439 million by 2050 (Olshansky et al., 2009).
Much of the overall estimated U.S. population growth is attributed to the increasing
proportion of the old, those aged 65+. Estimated to rise to 20% of the total population by
2050, this group will have grown from a mere 4% at the beginning of the 20th century
(McLaughlin et al., 2010). The 16% increase in growth means that around 84 million
Americans will comprise the 65+ population (Baernholdt, Hinton, Yan, Rose, & Mattos,
2012). Within the 65+ age group, the proportion of Americans reaching advanced old
age has also become more commonplace, further contributing to the overall U.S.
population growth rate. Of those men and women born in 1900 who lived until at least
65 years of age, 41% and 62% also reached age 80, respectively (Ailshire, BeltránSánchez, & Crimmins, 2011). Of the approximately 84 million Americans estimated to
be age 65+ by 2050, nearly 21 million will be over the age of 85 (Baernholdt et al.,
2012). Considering that only 5.4 million Americans were 85 years or older in 2008, it is
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apparent that great strides in aging are expected to continue (Olshansky et al., 2009).
Looking at subsets of Americans within the 65+ age group, racial and ethnic minority
populations are also expected to grow, increasing from 16.4% of the elderly in 2000 to
25.4% by 2050 (Trask, Hepp, Settles, & Shabo, 2009). Comparing 2000 statistics to
2050 estimates, White individuals will decrease from representing 84% of the 65+
population to 64%, while African American individuals will increase from 8% to 12%,
Asian individuals will increase from 2% to 7%, and Hispanic individuals will increase
from 6% to 16% (Trask et al., 2009). Although minority elder populations are expected
to grow, inequalities in aging are still evident. For instance, in 2002, life expectancy for
African Americans and Whites differed by almost six years, with an expected lifespan of
72.3 and 77.7 years, respectively (Weaver & Rivello, 2006).
2.1.3 Conditions of Aging in U.S.
As the U.S. elderly population continues to grow, much concern is being directed
toward the fulfillment of living longer healthier, happier lives. One of the leading
concepts in the field involves the notion of successful aging, which includes components
such as avoiding disease and disability, maintaining high levels of physical and cognitive
function, and staying involved in social activities (Hank, 2011). A recent study reports
that as of 2004, only about 11% of Americans age 65+ meet the criteria of successful
aging. Furthermore, the prevalence of successful aging has shown decline since 1998,
according to their analysis (McLaughlin et al., 2010). Much of the disease faced by the
older U.S. population consists of lingering chronic conditions. As of 2009, statistics
provide that 80% of adults over age 50 suffer from at least one chronic diagnosis
(Lehning & Austin, 2010). In addition to chronic disease, many older Americans also
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face the risk of generally limiting conditions. Research shows that in 2005, 40% of older
adults lived with some type of disability (Lehning & Austin, 2010). Moreover, in 2006,
studies suggest that 20% of older adults were disabled due to chronic disease alone
(McLaughlin et al., 2010). Higher levels of chronic conditions and disability create
extreme difficulties in maintaining physical function. Assessment of functioning often
involves an individual’s ability to engage in activities of daily living (ADL’s), such as
eating, toileting, dressing, bathing, and walking (Berlau, Corrada, & Kawas, 2009). By
age 90, up to 51% of elders have been shown to struggle with five or six ADL’s, with
28% completely relying on others for help when performing such activities (Berlau et al.,
2009). Existing with the alarmingly low successful aging rates in the U.S. are disparities
that remain disconcerting. For example, individuals with lower incomes are 62% more
likely to face moderate to severe disability than those with higher incomes (Huguet,
Kaplan, & Feeny, 2008). Additionally, studies report that aging White individuals tend
to maintain better physical health and cognitive function than aging African Americans
(Ailshire et al., 2011). Generally, it appears that the odds of aging successfully are higher
for White individuals, those with higher socioeconomic status (SES), and women
(McLaughlin et al., 2010).
2.2 Death and Dying in the U.S
2.2.1 Mortality
Over the past 40 years, the U.S. has experienced a significant decline in overall
death rates. Compared to the 1,242 per 100,000 age-standardized death rate in 1970,
there was a 32% decrease by 2002, resulting in a 845 per 100,000 age-standardized death
rate (Jemal, Ward, Hao, & Thun, 2005). As of 2000, the leading causes of death were
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heart disease, malignant neoplasms, cerebrovascular diseases, chronic lower respiratory
disease, and unintentional injuries (Mokdad et al., 2004). It is important to note,
however, the underlying leading actual causes of death: tobacco, poor diet and physical
inactivity, alcohol consumption, microbial agents, and toxic agents (Mokdad et al., 2004).
Related primarily to changes in lifestyle associated with chronic illness, studies suggest
that around 50% of deaths that year may have been preventable (Mokdad et al., 2004).
From 1990 to 2000, deaths attributable to smoking increased almost 9%, while deaths
attributable to diet and inactivity increased by 33%, and deaths attributable to alcohol
consumption decreased by almost 18% (Mokdad et al., 2004). Such staggering statistics
highlight the influence of behavior on overall mortality. Although death rates have
declined, certain factors have been linked to increased mortality, particularly race and
ethnicity. For example, data shows that throughout the 20th century there was an African
American-White male mortality difference of around 17-18% (Sloan, Ayyagari, Salm, &
Grossman, 2010). Additionally, as evidenced by 2002 data, the age-adjusted mortality
rate for Whites was 829, as opposed to 1083.3 for African Americans (Weaver & Rivello,
2006). Also closely related to race and ethnicity, death rates by cause differ between
populations. In 2002, African Americans and Whites were similar in regards to the
ranking of the top three leading causes of death (heart disease, malignant neoplasms, and
cerebrovascular disease); however, diabetes mellitus ranked fourth for African
Americans, instead of chronic lower respiratory disease (Weaver & Rivello, 2006).
Compared to both African Americans and Whites in the same year, Hispanic or Latino,
Asian or Pacific Islander, and American Indian or Alaska Native populations all
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experienced lower overall mortality rates, at 629.3, 474.4, and 677.4, respectively
(Weaver & Rivello, 2006).
In addition to race, SES and sex have also been shown to play a major role in
disparities related to mortality. For instance, 2001 data illustrates that African American
males with less than 12 years of education have an age-standardized death rate of 1211,
while African American males with greater than 16 years of education are affected by a
lower rate of 386.5 (Jemal et al., 2008). African American females in the same education
scenario experience death rates of 577.6 versus 318.7 (Jemal et al., 2008).
Correspondingly, inequalities connected to mortality and both sex and education hold
true for the White population, albeit at lower rates than in the African American
population. White males with less than 12 years versus those with more than 16 years of
education experience mortality rates of 914.6 and 216.2, while White females experience
rates of 539.5 and 147.4, in the same situation (Jemal et al., 2008). Ultimately, evidence
suggests that each year the following populations experience more deaths than their
counterparts: men, African Americans, and individuals having lower SES.
2.2.2 Onset of Death
Unfortunately, in the U.S., death largely remains a taboo topic. Research
documents that death is not only feared by Americans, but that both historic and current
cultures support the denial of death (Wasserman, 2008). Furthermore, academics submit
that medical and pharmacological technologies have played a large role in attempts to
postpone and renounce death; however, at some point, death becomes unavoidable (BernKlug, 2009). With the rise in chronic disease-related deaths, assessing approaching death
and end-of-life matters proves increasingly difficult. One popular concept addressing
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such challenges is the “ambiguous dying syndrome”, which clearly identifies social and
medical factors related to the health status of patients who are healthy or compromised
versus those who are terminally ill (Bern-Klug, 2004). The difficulty arises when
considering patients who fall in the middle of the spectrum, the severely compromised –
those experiencing conditions that are not quite recoverable or in the earliest stages, but
at the same time, are not in advanced or final stages (Bern-Klug, 2004). Data shows that
around 60% of contemporary deaths may involve levels of ambiguity, creating confusion
related to the appropriate medical approach, expectation of death, expectation of
recovery, and patient’s social role (Bern-Klug, 2004). Another theory related to
assessing end-of-life matters takes into consideration differing courses of degeneration.
The “trajectories of decline” model insinuates that those with chronic illness follow one
of three paths: long-term decent functioning with a quick decline to death in weeks or
months, slow decline with sudden death during an episode of exacerbation, or long-term
diminishing function necessitating years of personal care (Batchelor, 2010). Estimates
propose that 20% of individuals experience the first trajectory, while 25% and 40%
experience trajectory two and three; only about 15% of deaths appear to relate to sudden
illness or accidents (Batchelor, 2010). The difficulties involved in anticipating death for
Americans requiring long-term care, along with uncertainties regarding methods of
treatment and the tendency to ignore end-of-life matters until it is too late, creates the
need for urgent improved attention to the process of dying.
2.2.3 Conditions of Death
While the majority of Americans report a preference for home death, many face
end-of-life in less desirable surroundings. Systematic literature reviews illustrate the
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importance of dying at home for 59% to 81% of the general population; however, around
half of all chronic disease-related deaths in 2001 still occurred in acute care hospitals
(Gruneir et al., 2007). Avoiding death in the acute care setting does not necessarily
translate to the desired home death for the remaining half of the population, though. The
proportion of nursing home deaths has grown rapidly in the past 12 years, with around
25% of Americans facing end-of-life in such institutions (Gruneir et al., 2007). Like
many other aspects of healthcare, disparities related to place of death are well
documented. For example, one U.S. study reports that only about 16% of dementia
patients die in the acute care setting, as compared to the 50% average rate experienced by
most chronic patients, and that, instead, 67% experience dementia-related death in
nursing homes (Mitchell, Teno, Miller, & Mor, 2005). In addition to disease-related
disparities, other factors have also been linked to place of death. Studies show that being
White or living in less racially diverse areas predicts a home death, whereas being a
minority predicts death in the acute care setting (Gruneir et al., 2007). Also, higher odds
of hospital death are cited for less educated individuals or those who have less access to
social support (Gruneir et al., 2007).
Regarding preference, place of death is not the only important factor influencing
the end-of-life experience. Research, both domestic and abroad, demonstrates that a
meaningful death includes important concepts such as timeliness and lack of pain, and
that emphasizing the value of personal relationships and promoting feelings of
connectedness remain priorities for dying patients and their families (Long, 2004). The
“meaningful death”, however, is only one of many definitions related to the notion of
dying well. Another popular framework, the “good death”, promotes physical and
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psychological comfort, awareness, agency, and autonomy and acceptance, ending in
peaceful closure (Watts, 2012). Additionally, the “dignified dying” concept stresses
psychological and spiritual care, patient autonomy and control, quality of interactions,
and privacy boundaries during the end-of-life journey (Coenen, Doorenbos, & Wilson,
2007). Moreover, the “respectful death model” focuses more broadly on professional
caregivers building personal, close relationships with patients and families to provide
overall support during end-of-life (Wasserman, 2008). Although many of the concepts
fostering positive end-of-life experiences contain slight variations, overall, they generally
define aspects that lead to the avoidance of negative or bad death situations.
Evidence suggests that place of death and the odds of a positive death experience
may be strongly correlated, which, for many Americans, translates to undesirable
circumstances. Much of the literature regarding hospital-based deaths demonstrates
overaggressive measures and lack of comfort care, as perceived by family members, with
loved ones experiencing end-of-life symptoms like pain, shortness of breath, and
dysphoria (Galanos et al., 2012). Research supports the view that hospitals often offer
surroundings incompatible with a good death. For example, one study estimates that
around 50% of hospital staff and over 70% of nurses know their dying patients for less
than two days, and that attending physicians, nurses, and other medical staff rarely ever
agree on proper end-of-life care protocol (Galanos et al., 2012). Likewise, research also
validates that end-of-life care in the nursing home is deemed less than exemplary and is
the institution with, perhaps, the greatest room for improvement (Bern-Klug, 2009).
Well-documented complaints portray nursing home physicians as “missing in action” and
criticize hospice enrollment rates that occur too late, as well as the tendency for residents
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to be transferred to hospital intensive care units as they near death (Bern-Klug, 2009).
Accordingly, uncertainty remains regarding the ability of institutions to facilitate positive
death experiences by providing necessary components such as education and
explanations for family members, grief work facilitation, and advocacy of patient wishes
(Coenen et al., 2007).
Considering the statistics related to disparities in place of death and the lack of
evidence regarding the potential for a positive death experience in institutions, racial
minorities or individuals of lower SES seem to exhibit an unfair disadvantage in terms of
dying well. A multitude of analyses have not only validated disparities, but at the same
time have also exposed unsettling data. For instance, one study illustrated that cancerdiagnosed African Americans have increased odds for under treatment of pain, while
another report documented the likelihood of greater wait times for pain medication
administration for African American patients, regardless of diagnosis (Hazin & Giles,
2011). Analogously, an additional article declares that patients in facilities having
primarily minority residents are three times more likely to be under medicated than those
in institutions with residents of a majority population (Hazin & Giles, 2011). Along with
race and ethnicity and SES, other determinants of quality end-of-life care, like age and
expected death, have also been explored. A recent study looking at end-of-life care in the
hospital setting shows that patients under 75 years of age received worse overall care than
those 75 or older (Walling et al., 2010). Moreover, patients whose charts indicated
expected death three or more days before the actual occurrence experienced more
effective pain control than those with no such documentation (Walling et al., 2010). The
realities of widespread disparities in end-of-life care, together with the flawed institution-
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centered death model, leave much to be desired during Americans’ final days of life.
Although the U.S. spends almost twice as much per capita on healthcare than the 23 most
developed nations worldwide spend on average, end-of-life medical care remains
severely underfunded; the Economist Intelligence Unit ranks the U.S. 31 out of 40
countries in this regard (Hoefler, 2010). Disturbingly, according to the same report, the
U.S. ranks 9th for overall quality of death, followed closely by Hungary and Poland
(Hoefler, 2010).
2.3 End-of-Life Care in the U.S.
2.3.1 Palliative Care
In response to the fragmented end-of-life medical care most Americans receive,
the palliative care movement has recently gained momentum. Keeping the focus on
quality of life, regardless of diagnosis, palliative care is intended to provide comfort and
support to patients and families, irrespective of whether they choose to pursue curative
treatments (Meier, 2011). The palliative care model may be delivered in multiple settings
– the home, hospital, nursing home, or assisted living facility – and consists of an
interdisciplinary team of healthcare professionals who address disease, mental health,
family and social relationships, and spiritual needs (Meier, 2011). Proponents advocate
that palliative care should be practiced simultaneously with therapeutic efforts from the
moment a life-threatening illness is diagnosed, taking the form of primary, secondary, or
tertiary care (Meier, 2011). At the primary level, all physicians should strive to control
pain and symptoms; however, at the secondary level, many times the services of a
palliative care specialist are required for more complex situations. Additionally,
palliative care efforts may involve research or teaching at the tertiary level (Meier, 2011).
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Patients most often benefiting from palliative care services include those that are
struggling with a chronic disease that will one day lead to death or the elderly suffering
from overall debility and distress; nevertheless, few restrictions regarding patient-related
aspects of qualification exclude anyone in need of service (Batchelor, 2010). Conversely,
most of the limitations affecting access to palliative care services stems from the issue of
reimbursement on the provider side of the spectrum. While many professionals support
the notion of palliative care, reimbursement for certain services through Medicaid,
Medicare, and private insurance is not always guaranteed, forcing the institution to bear
any uncovered costs (Lubell, 2010). Currently, providing palliative care in the hospital
setting is the only way to ensure the most comprehensive reimbursement for healthcare
providers’ services; still, assistance from team members like chaplains, social workers,
and bereavement counselors is never considered billable in the palliative setting (Lubell,
2010).
Due to the restrictions placed on palliative care reimbursement, most programs
providing such services focus on the in-patient hospital environment. Estimates suggest
that at least 80% of hospitals with 300 or more beds offer formal palliative care programs
(Galanos et al., 2012). Even with availability of services in larger hospitals, one study,
examining end-of-life care at a well-respected university medical center, highlights the
truths associated with access to palliative care – only 7% of patients hospitalized for three
or more days were engaged in a palliative care consultation (Walling et al., 2010).
Similarly, in another study enrolling almost 1600 patients across 35 university hospitals,
palliative care consults were ordered for only about 13% of patients meeting end-of-life
criteria (O’Mahony et al., 2008). Given the difficulties related to reimbursement outside
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of the hospital, it is not uncommon to find poorer access to formal palliative care or endof-life programs in the nursing home setting. A nationally representative study recently
reported that out of nearly 1200 nursing homes, only about 17% of facilities even offered
a formal palliative care program at all (Resnick et al., 2009). Furthermore, the data
suggests that patients have a greater chance of being offered specialty end-of-life
programs in independent nursing homes, as well as in facilities that have fewer than 50
beds (Resnick et al., 2009).
When examining evidence addressing the efficacy of palliative care treatment at
end-of-life, it becomes apparent that few Americans receive holistic comfort care,
regardless of their diagnosis and decisions to pursue curative or restorative measures.
The literature presents little evidence suggesting that palliation is ineffective. On the
contrary, a recent systematic review looking at specialist palliative care teams and cancer
patients found that out of eight relevant randomized controlled trials, seven merited a
ranking of moderate to high evidence, providing significant outcome improvements for
pain and symptom control, reduced anxiety, and reduced hospital admissions (Higginson
& Evans, 2010). Combined with the substantiation regarding the efficacy of palliative
care in cancer patients, a recent study looking at differences between cancer and noncancer patients in palliative care programs in Germany indicates that patients with noncancer diagnoses benefit as much from palliation – or in some cases, even more – as their
cancer-diagnosed counterparts (Ostgathe et al., 2011). Compared with cancer patients,
those with non-cancer diagnoses had significantly worse functional status, significantly
higher needs for nurse support, and died significantly more often (Ostgathe et al., 2011).
Furthermore, the non-cancer patients were significantly more likely to suffer from
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dyspnea, weakness, and tiredness, as well as require more wound care and assistance with
ADL’s (Ostgathe et al., 2011).
2.3.2 Hospice Care
Another option for Americans facing terminal illness, hospice care offers most of
the same services associated with palliative care, with a more distinct focus on
approaching end-of-life. While palliative care provides the opportunity to continue
restorative treatments simultaneously, hospice care is intended for those individuals who
are estimated to have six months or less to live and wish to forego curative efforts,
concerned mainly with comfort, dignity, and quality of life remaining (Furman, Doukas,
& Reichel, 2010). Like the interdisciplinary team that oversees palliative care, the
hospice team provides much needed support including physician and nursing care, as
well as social work, counseling, chaplain and bereavement services (Lutz, 2011). In
addition to care services, the hospice benefit provides palliative medications, durable
medical equipment (e.g., wheelchairs and hospital beds), and supplies (e.g., adult diapers
and mouth care swabs) (Lutz, 2011). According to patient preference and level of
required support, hospice care is generally provided at a private residence, an in-patient
hospice unit, or in the hospital setting. As of 2010, at the time of death, 41.1% of patients
received hospice services at their private residence, while 18% and 7.3% received care at
nursing homes and residential facilities, respectively (“NHPCO Facts,” 2012).
Additionally, at the time of death, 21.9% of patients received care in hospice in-patient
facilities, and 11.4% of care was delivered in the hospital setting (“NHPCO Facts,”
2012). Outside of the in-patient setting, hospice services are generally regarded as
supplementary, since the interdisciplinary team visits the home regularly, but also
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requires the patient have a primary caregiver. While hospice staff are not typically able
to provide around-the-clock or even daily care, most agencies offer on-call services, in
case any issues arise (“NHPCO Facts,” 2012). Similar to the evidence regarding
effectiveness of palliative care, hospice has been shown to dramatically improve the endof-life experience. For instance, families exposed to hospice describe less unmet needs,
higher quality of death, and less anxiety regarding quality of care (Teno et al., 2011).
Since 1982, when Congress created a national hospice benefit, many Americans
have qualified for services under Medicare part A (Lutz, 2011). Upon election of the
Medicare Hospice Benefit, patients relinquish their access to the regular Medicare
Benefit for any care related to their terminal condition (Furman et al., 2010).
Accordingly, the Hospice Medicare Benefit covers the cost of hospice care at 100%, but
patients are still able to access their standard Medicare Benefit for unrelated health care
issues (Furman et al., 2010). For Americans not enrolled in Medicare, many state
Medicaid programs and private insurance plans also offer hospice care benefits, varying
in their levels of out of pocket-costs, deductibles, and covered services. As of 2010,
almost 84% of hospice patients were covered under Medicare, with around 5% covered
through a Medicaid program and nearly 8% covered by managed care or private
insurance (“NHPCO Facts,” 2012). The remaining 3% of hospice patients served in 2010
were covered as charity cases, through self-pay, or through other similar sources
(“NHPCO Facts,” 2012).
Even though there was a network of almost 5,000 U.S. hospice agencies as of
2008, the majority of Americans still face death without the comfort and support
provided by a qualified hospice team (Silveira et al., 2011). Of the approximately 2.45
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million U.S. deaths occurring in 2010, only around 1 million involved hospice services,
signifying that nearly 58% of Americans most likely lack appropriate pain control and
psychosocial care during their final days (“NHPCO Facts,” 2012). Although the total
number of Americans seeking hospice services over the past 20 years has multiplied at
least six times, additional progress related to end-of-life care remains necessary (Johnson,
Kuchibhatla, Tanis, & Tulsky, 2007). In addition to increasing the reach of hospice to
the proportion of dying Americans who are currently lacking, more work is required to
assure that the nearly 42% of patients using hospice services take full advantage of the
benefits. Though the hospice benefit provides 180 days of care and potentially more, if
the patient continues to meet terminal qualifications, roughly 62% of hospice patients in
2010 utilized services for less than one month (“NHPCO Facts,” 2012). Sadly, short
lengths of service create challenges for caregivers attempting to build trusting
relationships with patients and families, in order to foster positive deaths and provide the
highest level of end-of-life care.
Akin to the theme of disparities in service access and utilization in other areas of
health care, the literature confirms that the likelihood of receiving hospice care is not
uniformly distributed throughout the American population. Research shows important
differences regarding the probability of a hospice admission in relation to many other
crucial factors, such as sex, for example. Not only have previous studies cited females’
increased odds of hospice enrollment as compared to males, but the most recent statistics
regarding hospice use further substantiate this inconsistency (duPreez et al., 2008). In
2010, the majority of all hospice patients were female, with male patients representing
only 43.9% of the total hospice patient population (“NHPCO Facts,” 2012). In addition
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to sex, research highlights variances in hospice utilization by age group. In general, older
Americans remain more likely to engage hospice services than their younger counterparts
(Carrion et al., 2011). More specifically, according to 2010 data, almost 39% of all
hospice patients were 85 years or older, while around 28% were 75-84 years, roughly
16% were 65-74 years, and about another 16% were 35-64 years of age (“NHPCO
Facts,” 2012).
Another important factor appearing to influence the odds of enrolling in hospice
care is the nature of a patient’s diagnosis. Upon the introduction of hospice to the U.S.,
providers were focused on serving primarily individuals living with terminal cancer;
nevertheless, there has been a recent shift in the growing number of patients receiving
care for non-cancer terminal diseases (Johnson et al., 2007). In fact, as of 2010, almost
64% of all hospice patients were diagnosed with life-limiting diseases other than cancer
(“NHPCO Facts,” 2012). The top four non-cancer diagnoses, by percentage of hospice
admissions, in 2010 included heart disease (14%), debility unspecified (13%), dementia
(13%), and lung disease (8%) (“NHPCO Facts,” 2012). Diagnoses such as stroke, endstage renal disease, liver disease, ALS, and HIV/AIDS comprised the remainder of noncancer related hospice admissions (“NHPCO Facts,” 2012).
Closely paralleling the probability that Americans with lower SES will face less
positive death experiences, income, wealth, and education have all been documented as
key hospice use indicators. For example, a study found that each $1000 increment in
median household income corresponded to a 3% increase in hospice services supply in
counties across the U.S., potentially creating less access to end-of-life care for those
individuals living in more poverty-stricken areas (Silveira et al., 2011). Another study
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discusses their sample’s 20% hospice utilization rate for patients with incomes 300% or
greater than the federal poverty level, as opposed to a 14% utilization rate for those with
incomes less than 100% of the federal poverty level (O’Mahony et al., 2008). Also
emphasizing the issues related to SES, access to end-of-life care, and potential hospice
utilization, the authors of one study found that populations with a lower median
household income or lower educational attainment were significantly more likely to be
located more than 30 minutes from a hospice than their counterparts (Carlson, Bradley,
Du, & Morrison, 2010).
Perhaps the most pronounced disparities, race and ethnicity seem to play a vital
role in the acceptance and utilization of hospice services at the end-of-life. As of 2010,
estimates suggest nearly 77% of all hospice patients were White, while the remaining
patients identified as African American (8.9%), Asian/Hawaiian/Pacific Islander (2.5%),
American Indian/Alaskan Native (.3%), or multiracial/other (11%). Additionally, only
around 6% identified as Hispanic/Latino (“NHPCO Facts,” 2012). Confirming the
accuracy of such estimates, numerous studies report the troubling underuse of hospice
care by racial and ethnic minorities. In one study looking at almost 23,000 hospice
patients in Florida, around 81% of the sample was White, while around 10% were
African American, around 9% were Hispanic, and only about 1% were Asian/Pacific
Islander (Carrion et al., 2011). In another analysis, assessing hospice utilization for stoke
victims, the authors found that African Americans were significantly less likely to use
hospice services when compared to Whites (duPreez et al., 2008). Furthermore, another
investigation determined that non-Whites diagnosed with heart failure were also
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significantly less likely to enroll in hospice, as compared to their White counterparts
(Givens et al., 2010).
Despite the fact that African Americans exhibit the highest mortality rates in the
U.S., a considerable portion of the literature focuses on their underrepresentation in
hospice care. Although African American patients tend to report a greater need for the
types of services provided by hospice, research clearly indicates that they do not embrace
end-of-life care in the same manner as Whites (Fishman et al., 2009). While many
factors most likely result in such an outcome, treatment preferences appear to play an
important role in the hospice utilization gap. Opting for more aggressive care than
Whites, African Americans have been shown to have higher rates of artificial nutrition,
blood transfusions, and mechanical ventilation (Connolly, Sampson, & Purandare, 2012).
Moreover, in a study looking at cancer patients, African Americans were more likely than
Whites to continue treatment for a smaller chance of six-month survival (Fishman et al.,
2009). Overall, the idea of giving up curative treatment treatments to enroll in hospice
may very well create discordance with African American beliefs (Hazin & Giles, 2011).

	
  

	
  

Chapter III
Methods and Procedures
3.1 Background
The data analyzed in this study were obtained from the cross-sectional 2007
National Home and Hospice Care Survey (NHHCS), conducted by the Centers for
Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS).
This nationally representative data set, collected between August 2007 and February
2008, offers descriptive information regarding home health and hospice agencies, staff,
services, and patients (“NHHCS - National Home and Hospice Care Survey Homepage,”
n.d.). As part of a continuing series of surveys, the NHHCS has been conducted at
varying intervals since 1992. All participating hospice agencies were certified by at least
one of the following: Medicare, Medicaid, or the state in which patients were served.
3.2 Data Collection
Utilizing a stratified two-stage probability sample design, the NCHS first
systematically and randomly selected 1,545 home health and hospice agencies from a
sample frame of over 15,000 agencies (“NHHCS - National Home and Hospice Care
Survey Homepage,” n.d.). Then, during interviews, staff randomly selected current home
health patients and hospice discharges from agency census lists, with the assistance of a
computer algorithm. After eliminating agencies outside of the scope of the survey,
information was collected in-person from a total of 1,036 hospice and home health
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agencies via directors and staff – no patients or patient representatives were interviewed.
Agency interviews, along with information collected from medical records, provided
details for a total of 9,416 current home health patients and hospice discharges after
eliminating those outside of the survey scope. Of the 9,416 final patients/discharges
surveyed, 4,733 were hospice cases. Data available for these cases include details such
as age, sex, race and ethnicity, diagnoses, and medications taken.
3.3 Variables Selected
From the available data, the following sociodemographic (independent) variables
were chosen for this analysis: sex, age at time of discharge, Hispanic/Latino ethnicity,
race, primary source of payment for hospice care, and deceased status upon discharge.
Regarding sex, response options were limited to male or female. The data set treated age
at time of discharge as a continuous variable; therefore, responses were recoded into the
following categorical groups for the purposes of this study: 18-34, 35-64, 65-74, 75-84,
and 85+. The question regarding Hispanic/Latino ethnicity was answered with a simple
yes or no response. Regarding race, options included White, Native Hawaiian/Pacific
Islander, African American, Asian, American Indian/Alaska Native, and other.
Discharges could be classified as more than one race, and those with an “other” response
were treated as missing. Regarding source of payment, discharges were primarily
covered by one of the following: Medicare, Medicaid, TRICARE (formally CHAMPUS),
Department of Veterans Affairs, CHAMPVA, other government, private insurance, longterm care insurance, self-pay (patient/family), no charge for care, payment source not
determined, or other. In order to make results more manageable, the variable was
recoded into the following options: no charge/other, self-pay, private insurance, other

	
  

26
government, Medicaid, or Medicare. For deceased status upon hospice discharge,
responses included a simple yes or no answer.
In addition to selected sociodemographic variables, clinical (independent)
variables were also analyzed in this study, including location hospice was initiated, length
of stay in days, level of care at discharge, number of ADL’s requiring help, cognitive
function at admission/currently, and symptoms of dyspnea, depression, or pain at last
visit. Categorical options for the question, “where was patient staying when (he/she) first
began receiving hospice care?” (location hospice initiated), were: agency’s
inpatient/residential facility, private home or apartment, residential care place, skilled
nursing facility (nursing home), hospital, or other. The data set treated “number of days
patient received hospice care” (length of stay) as a continuous variable, which, for the
purpose of this study, was recoded into five corresponding categories: 180+, 90-179, 3089, 8-29, and < 7.
Categorical possibilities regarding level of care at discharge included routine
home care, continuous home care, general inpatient care, and respite care. Cases
classified as unknown, refused, or inapplicable were treated as missing. Regarding the
number of ADL’s requiring help, which includes assistance with bathing, dressing,
transferring, walking, or eating, available categorical responses were zero to five. Again,
those cases classified as unknown, refused, or inapplicable were treated as missing. For
mental status (cognitive function at admission/currently), categorical responses included
no cognitive impairment, requires occasional reminders, requires situational assistance,
requires routine assistance, or severe cognitive impairment; unknown, refused, or
inapplicable selections were treated as missing. Symptoms of dyspnea, pain, and
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depression at last visit were treated as simple categorical yes or no responses. Cases with
unknown, refused, or inapplicable selections were treated as missing, as well.
The dependent variable in this analysis – hospice diagnosis – was determined
from the response to each discharge’s primary admission diagnosis when first beginning
hospice service. Potential responses included any valid International Classification of
Diseases (ICD-9) code. For comparison purposes, all ICD-9 diagnosis codes were
recoded into a main categorical variable, producing two independent groups: cancer vs.
non-cancer.
3.4 Statistical Analysis
All statistical analysis was performed using PASW Statistics 18 (SPSS, Inc.,
2009, Chicago, IL). In order to determine the distribution of diseases for the sample of
discharges, ICD-9 codes were recoded into their corresponding categorical diagnosis
groups. Prevalence of disease was then determined by running descriptive frequencies.
Additionally, descriptive frequencies were also run for all sociodemographic and clinical
variables, in order to determine the prevalence of each. Next, the two diagnosis groups
(cancer vs. non-cancer) were compared by each sociodemographic and clinical variable
through chi-square tests of independence, evaluating the existence of any between-group
differences. Differences were considered significant for p-values less than 5%. In order
to better describe relationships between the sociodemographic and clinical variables and
hospice diagnosis, logistic regression was performed. Any independent variables that
differed significantly during chi-square testing were evaluated for association with
hospice diagnosis through univariate logistic regression procedures. Finally, in an
attempt to control for potential confounders, all independent variables with significant
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chi-square results were combined in one multivariate logistic regression model. Overall
relationships were determined by odds ratios, and significance was indicated by 95%
confidence intervals.

	
  

	
  

Chapter IV
Results
4.1 Distribution of Diseases
The 2007 NHHCS dataset contained a total of 9,416 patient cases. Of those,
3,905 cases met study inclusion criteria: having a hospice discharge, being a patient age
18 or over, and detection of complete survey responses for selected variables. In terms of
disease prevalence (Table 1), 1,865 (47.8%) discharges entered hospice care with a
cancer diagnosis. The remaining 2,040 (52.2%) discharges entered with a non-cancer
diagnosis. The top non-cancer diagnoses were comprised of discharges exhibiting
diseases of the circulatory system; 614 (15.7%) individuals suffered from illnesses such
as heart disease, heart failure, or cerebrovascular disease. The second most common noncancer group, “other”, included mainly those diagnosed with failure to thrive or debility
unspecified and contained 485 (12.4%) discharges. Respiratory system illnesses ranked
third, as 304 (7.8%) discharges were diagnosed with diseases such as pulmonary fibrosis
or chronic airway obstruction. Ranking fourth, 234 (6%) discharges were diagnosed with
nervous system disorders, including Parkinson’s disease, multiple sclerosis, and muscular
dystrophy. The fifth most common non-cancer diagnosis included organic psychotic
conditions such as dementia – 206 (5.3%) discharges exhibited these types of terminal
diseases. Other less common non-cancer diagnoses represented were HIV/AIDS and
diseases of the digestive, genitourinary, and musculoskeletal systems.
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4.2 Comparison of Cancer/Non-cancer Diagnoses by Sociodemographics
Evaluating the prevalence of selected sociodemographic variables in relation to
hospice diagnosis (Table 2), the majority of the non-cancer group, 1,228 (60.2%)
discharges, identified as female, while the majority of the cancer group, 959 (51.4%)
discharges, identified as male. Accordingly, a significant difference regarding sex
prevailed between the two hospice diagnosis groups (X2 (1) = 53.052, p < .001). For noncancer diagnoses, an age of 85 years or older was most common, with 1,011 (49.6%)
discharges classified in the corresponding age range. In contrast, the most common age
for a cancer diagnosis ranged between 75 and 84 years, with this category including 605
(32.4%) discharges. A significant age difference between the two hospice diagnosis
groups was discovered (X2 (4) = 612.399, p < .001). Comparing ethnicity between the
two hospice diagnosis groups, 52 (2.5%) non-cancer discharges and 54 (2.9%) cancer
discharges were reported as having a Hispanic/Latino origin. No significant difference
between the two diagnosis groups was found in regards to ethnicity (X2 (1) = .443, p =
.506).
The majority of both non-cancer and cancer hospice discharges were White,
totaling 1,842 (90.3%) and 1,727 (92.6%), respectively. Analysis showed a significant
difference in White racial status between the two diagnosis groups (X2 (1) = 6.591, p =
.010). The second most common racial status was African American, with 154 (7.5%)
non-cancer discharges and 108 (5.8%) cancer discharges represented. Results exposed a
significant difference in African American racial status between the two diagnosis
groups, as well (X2 (1) = 4.811, p = .028). No significant differences between diagnosis
groups were discovered regarding Native Hawaiian/Pacific Islander, Asian, and
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American Indian/Alaska Native racial status. For primary source of payment, most
utilized Medicare benefits – 1,909 (93.6%) non-cancer discharges and 1,341 (71.9%)
cancer discharges. However, a significant difference was noted when comparing the two
diagnosis groups in terms of primary payment source (X2 (5) = 343.545, p < .001). Upon
discharge, 1,511 (74.1%) non-cancer diagnosed hospice patients and 1,641 (88%) cancer
diagnosed hospice patients were deceased, highlighting a significant difference between
the two groups’ prevalence of death (X2 (1) = 121.302, p < .001).
4.3 Comparison of Cancer/Non-cancer Diagnoses by Clinical Characteristics
Upon assessment of the prevalence of selected clinical variables in relation to
hospice diagnosis (Table 3), private residences and nursing homes were the most
common locations hospice was initiated for both diagnosis groups. For the non-cancer
group, 1,058 (51.9%) discharges began hospice service at home, while 585 (28.7%)
discharges were served in a nursing home. In the cancer group, 1,459 (78.2%) discharges
also received care at their home, and 179 (9.6%) discharges participated in a hospice
program in a nursing home facility. Overall, a statistically significant difference was
detected in the location of hospice service initiation between the two groups (X2 (5) =
358.319, p < .001). Regarding length of stay, 1,015 (49.8%) non-cancer discharges and
1,144 (61.4%) cancer discharges received 29 days or less of hospice care services.
Correspondingly, only 376 (18.4%) non-cancer and 120 (6.4%) cancer discharges
received hospice services for at least 180 days. The between group differences related to
length of stay were found to be statistically significant (X2 (4) = 171.772, p < .001).
Examining the level of care at time of discharge, most non-cancer and cancer discharges
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were classified as routine homecare, and the difference between both groups did not hold
significance (X2 (3) = .704, p = .872).
Most discharges in both diagnosis groups required assistance with three to five
ADL’s. Assistance with four ADL’s was the most common response, as evidenced by
649 (31.8%) non-cancer and 520 (27.9%) cancer discharges’ needs. Results indicate
significant differences between the two groups and their requirement of assistance with
ADL’s (X2 (5) = 148.092, p < .001). In terms of level of cognitive function at
admission/currently, the most common response for the non-cancer diagnosed group was
the need for routine assistance, with 626 (30.7%) discharges included. However, the
most common response for the cancer diagnosis group was no cognitive impairment, with
880 (47.2%) discharges included. Differences in cognitive function at
admission/currently significantly differed between the two diagnosis groups (X2 (4) =
524.468, p < .001). Upon assessment of symptoms that were present at the most recent
hospice visit, 872 (42.7%) non-cancer discharges experienced dyspnea, as opposed to the
894 (47.9%) cancer discharges exhibiting the same issue. This symptomatic difference
between the two groups proved statistically significant (X2 (1) = 10.596, p < .001). With
181 (8.9%) non-cancer discharges and 138 (7.4%) cancer discharges reported as
depressed, such between group differences remained insignificant (X2 (1) = 2.818, p =
.093). Finally, when addressing pain, 521 (25.5%) non-cancer discharges and 708 (38%)
cancer discharges faced challenges. Like dyspnea, analysis of pain presence during the
previous hospice visit resulted in significant differences between the two diagnosis
groups (X2 (1) = 69.721, p < .001).
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4.4 Univariate Logistic Regression
Univariate logistic regression analysis revealed quite a few important predictive
relationships between the classification of terminal hospice diagnosis (cancer vs. noncancer) and selected sociodemographic and clinical variables (Table 4). Regarding the
relationship with sex, females appeared significantly less likely to enter hospice with a
cancer diagnosis than males (OR = 0.625; 95% CI: 0.550, 0.709). Considering a link
with age, hospice discharges in the 75-84 age range were significantly less likely to enter
hospice care with a cancer diagnosis, as compared to other age groups (OR = 0.226; 95%
CI: 0.064, 0.797). Similarly, the 85+ age group also proved significantly less likely to
have a cancer diagnosis at time of admission (OR = 0.072; 95% CI: 0.020, 0.256).
Concerning an association with race, White hospice discharges were significantly more
likely to admit with a cancer diagnosis (OR = 1.345; 95% CI: 1.072, 1.688), while
African American’s were significantly less likely to do so (OR = 0.753; 95% CI: 0.584,
0.971). Examining a potential relationship with primary payment source, results
indicated that hospice discharges with private insurance were significantly more likely to
have a cancer diagnosis (OR = 3.246; 95% CI: 1.809, 5.824), and that those with
Medicare were significantly less likely to enter hospice care with cancer (OR = 0.337;
95% CI: 0.206, 0.551). Also, discharges that were deceased were significantly more
likely to have been diagnosed with cancer (OR = 2.565; 95% CI: 2.161, 3.044).
Results proved significant for three of the six categories related to place of
hospice service initiation. Hospice discharges beginning care in their private homes were
more likely to have a cancer diagnosis (OR = 1.915; 95% CI: 1.400, 2.619), whereas
those initiating care in a nursing home were less likely to have cancer (OR = 0.425; 95%
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CI: 0.301, 0.601). Additionally, hospice discharges beginning services in residential care
facilities were even less likely to have a cancer diagnosis (OR = 0.313; 95% CI: 0.196,
0.500). Regarding length of stay, hospice discharges receiving less than 180 days of
services were all significantly more likely to belong to the cancer diagnosis group.
However, discharges receiving only 8-29 days of hospice care were significantly most
likely to be admitted with cancer (OR = 4.238; 95% CI: 3.345, 5.370). In terms of
needing help with ADL’s, hospice discharges requiring assistance with two to five
activities were all significantly less likely to have a cancer diagnosis documented.
Hospice discharges that struggled with five ADL’s were least likely to be diagnosed with
cancer (OR = 0.284; 95% CI: 0.220, 0.366). Looking at cognitive function upon
admission/currently, hospice discharges with any level of impairment whatsoever were
deemed significantly less likely to belong to the cancer diagnosis group. Particularly,
discharges with severe cognitive impairment were the least likely to enter hospice care
with cancer (OR = 0.095; 95% CI: 0.073, 0.124). Lastly, significant associations were
found in relation to both dyspnea and pain symptoms and hospice diagnosis. Discharges
that experienced dyspnea were more likely to have cancer (OR = 1.233; 95% CI: 1.087,
1.399), as were those patients who faced pain (OR = 1.784; 95% CI: 1.556, 2.045).
4.5 Multivariate Logistic Regression Model
When controlling for potential confounders in the multivariate logistic regression
model (Table 5), many of the associations between hospice diagnosis and
sociodemographic and clinical variables remained significant; however, noteworthy
changes occurred. One of the relationships no longer considered significant, females
were found only very slightly less likely to admit to hospice with a cancer diagnosis

	
  

35
when compared to males (OR = 0.920; 95% CI: 0.787, 1.074). Another adjustment, the
only significant relationship between age and diagnosis was found in the 85+ group, as
they continued to be much less likely to enter hospice care with a cancer diagnosis (OR =
0.254; 95% CI: 0.066, 0.976). In addition to sex, race was determined to be of no
significant relation to hospice diagnosis for both White (OR = 1.664; 95% CI: 0.930,
2.975) and African American discharges (OR = 1.273; 95% CI: 0.667, 2.430). Regarding
primary source of payment, multivariate regression indicated that the only significant
association with hospice diagnosis remained private insurance, which led to a greater
likelihood of having cancer (OR = 2.458; 95% CI: 1.268, 4.765). While still proving
significantly related to the chance of a cancer diagnosis, the odds ratio for being deceased
upon hospice discharge increased slightly (OR = 3.041; 95% CI: 2.440, 3.790).
The only significant association between hospice diagnosis group and location of
hospice initiation was found for those discharges located at a private residence.
Beginning hospice service in one’s own home predicted a much greater chance of cancer
diagnosis (OR = 1.806; 95% CI: 1.243, 2.625). Like the results from univariate analysis,
all lengths of stay shorter than 180 days were significantly associated with increased
chances for a cancer diagnosis. Moreover, a length of stay ranging from 8-29 days
carried the highest odds of being linked to a cancer diagnosis (OR = 3.043; 95% CI:
2.296, 4.033). Also similar to univariate results, the relationship between the number of
ADL’s requiring help and type of cancer diagnosis continued to exist. Hospice
discharges requiring assistance with two to five ADL’s were found significantly less
likely to admit with a cancer diagnosis when compared to individuals who needed help
with zero to one activity. Specifically, those discharges relying on assistance with three
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ADL’s were least likely to be classified with a cancer hospice diagnosis (OR = 0.471;
95% CI: 0.339, 0.655). Additionally, the association in regards to level of cognitive
function at admission/currently and hospice diagnosis continued to show significance.
All levels of cognitive function involving any impairment, even if only slight, predicted
less chance for a cancer diagnosis, with severe cognitive impairment being the least likely
(OR = 0.148; 95% CI: 0.108, 0.201). Finally, while pain symptoms still proved
significantly related to hospice diagnosis, predicting an increased chance that a discharge
admitted for cancer (OR = 1.583; 95% CI: 1.338, 1.872), the association between
diagnosis and dyspnea lost significance (OR = 0.855; 95% CI: 0.731, 1.002).

	
  

	
  

Chapter V
Discussion and Conclusion
This study explores potential disparities related to the use of hospice care, as
observed between individuals who presented with terminal cancer diagnoses versus those
who presented with other non-cancer terminal diseases. Of particular interest were
details regarding main differences between the two hospice diagnosis groups and the
degree to which hospice patient characteristics are related. After controlling for both
sociodemographic and clinical variables in a multivariate logistic regression model,
results confirmed significant relationships between a cancer vs. non-cancer hospice
diagnosis classification and multiple patient characteristics, largely those of clinical
nature. However, important differences concerning sociodemographics also emerged.
Descriptive analysis showed that the majority of hospice discharges involved in
this study were seeking comfort care for a non-cancer related disease. The most common
non-cancer diagnoses consisted of conditions such as heart disease, cerebrovascular
disease, failure to thrive, debility unspecified, and pulmonary disease. While results do
parallel other data suggesting a non-cancer majority, findings from this study regarding
estimated proportions of cancer vs. non-cancer diagnoses differ slightly. Another U.S.
study, looking at racial differences and non-cancer hospice diagnoses, found that only
around 40% of their sample presented with cancer, in comparison to the nearly 48% in
this study (Johnson et al., 2007). Although not entirely nationally representative, their
sample did include patients from eight states in differing geographic locations.
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Accordingly, it is more likely that their observation of less cancer patients relates to a
larger sample size, including approximately 162,000 more cases than this study. In terms
of distribution of non-cancer terminal disease, results from this study generally agree
with the National Hospice and Palliative Care Organization’s most recent findings from
2010 data (“NHPCO Facts,” 2012).
Descriptive analysis also revealed that over 90% of all hospice discharges
included in this study identified as White, racially. In comparison, only about 7% of total
discharges identified as African American. The remaining minority identified racially as
American Indian or Alaska Native (~1%), Asian (~1%), or Native Hawaiian or Pacific
Islander (.2%). In terms of ethnicity, only about 3% of discharges were considered to be
of Hispanic or Latino origin. While certainly concerning, the racial divide found in this
study is not a new concept. In a study conducted in Florida around the same time,
authors reported their sample to be primarily represented by White patients (~81%),
while African Americans accounted for almost 10%, Asian Americans or Pacific
Islanders accounted for .5%, and around 9% were of Hispanic ethnicity (Carrion et al.,
2011). It is quite possible that the minimal differences in terms of racial composition
between the two studies may be attributed to their less-generalizable sample, gathered
from only one agency in central Florida. While differences in comfort care utilization
likely stem from multiple causes, research has shown that some races, particularly
African Americans, often have misconceptions about hospice services or lack awareness
of such care altogether (Enguidanos, Kogan, Lorenz, & Taylor, 2011). Also related to
race, culture and spirituality/religion have been found to shape end-of-life decisions,
remarkably those addressing treatment options (Bosma, Apland, & Kazanjian, 2010).
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The comparison of cancer to non-cancer hospice discharges in this study revealed
significant sociodemographic and clinical differences between the two diagnosis groups,
potentially pointing to important hospice utilization disparities. Thus, each significant
between-group difference was further examined in an attempt to more concretely
describe relationships between variables. Addressing sex, women comprised the majority
of non-cancer diagnoses and males dominated the cancer group, as comparably noted in
other palliative care research (Ostgathe et al., 2011). It is possible that observed sex
differences in hospice utilization might stem from inherent biological processes affecting
disease epidemiology – those that also play a role in the average life expectancy gap
between American males and females. Interestingly, although unadjusted odds of a
cancer diagnosis were significantly lower for females during regression analysis, final
adjusted odds resulted in no significant relationship between sex and hospice diagnosis.
Though all racial minorities utilized hospice much less than Whites, there were no
significant racial differences found between non-cancer and cancer diagnoses for
American Indians/Alaska Natives, Asians, or Native Hawaiians/Pacific Islanders.
Nevertheless, African Americans admitted significantly more for non-cancer diagnoses,
while Whites were significantly more often diagnosed with cancer. Since hospice
services generally require patients to forego curative efforts for comfort care, this
observation is logical, as research has shown African Americans many times elect more
aggressive measures than Whites, expressly when continuing cancer treatments (Fishman
et al., 2009). Much like the analysis of sex, unadjusted odds of a cancer diagnosis were
significantly higher for Whites and lower for African Americans, but no significant
relationship resulted when examining adjusted odds in regards to race and diagnosis. It is
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important to note, however, that the 95% confidence intervals were very close to
significance for both sex and White race variables. The listwise method utilized in
cleaning data for this study could be one potential explanation for the barely insignificant
adjusted results, depending on whether a disproportionate number of African American
cases were missing data and excluded from analysis.
Examining differences in age, the non-cancer group was mostly comprised of
discharges 75 years and older. On the other hand, the majority of cancer diagnoses
occurred in discharges ages 35-84. Similarly, one study reported a majority of noncancer patients over the age of 65 and majority of cancer patients age 65 or under, which
suggests that cancer may more often affect those in adulthood or middle age than those
considered old (Johnson et al., 2007). In this study, regression analysis produced
adjusted odds indicating that discharges 85 and older are significantly less likely to enroll
with a cancer hospice diagnosis. The Johnson study found the same significant
relationship for age; however, it applied to hospice patients 65 and older. The conflicting
age results may be related to the number of categories included in each analysis – this
study contained five age categories, while theirs only utilized two.
In terms of medical coverage, the results of this study agree with previous
research. Even though the majority of all discharges used Medicare as a primary
payment source, private insurance or Medicaid covered those with cancer diagnoses more
often than their non-cancer counterparts. Such a finding may be substantiated by the fact
that nearly 30% of all cancer discharges were between the ages of 18 and 64, creating
increased likelihood for Medicare ineligibility. Ultimately, adjusted odds signify that
private insurance increases the chances of admitting with cancer, which has also been
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shown in other studies looking at health maintenance organizations and hospice
diagnoses (Johnson et al., 2007).
Regarding status upon hospice discharge, fewer non-cancer diagnosed individuals
were deceased when compared to those with cancer. Additionally, adjusted odds
validated the relationship between discharge status and diagnosis, showing that cancer
diagnoses are significantly more likely to be deceased at the end of their hospice stay.
Compared with other research, this finding certainly makes sense. Estimates exist
claiming that live discharges occur anywhere from 6-15% of the time, due to improved or
stabilized conditions or the decision to pursue more aggressive treatment. Furthermore,
studies show that live discharge status and a non-cancer diagnosis are related (Enck,
2011).
While more cancer than non-cancer discharges began hospice services at their
private homes, the opposite was observed with regards to beginning services at
residential care facilities and nursing homes. Accordingly, multivariate regression
specified a significant relationship between location of hospice initiation and diagnosis,
providing that discharges beginning hospice at home were more likely to have cancer.
Such a finding seems appropriate, due to the fact that facilities offer additional services
unavailable in the home, and research has shown that non-cancer hospice patients exhibit
poorer functional status and higher needs for nursing support (Ostgathe et al., 2011).
Moreover, results from this study also support a functionality difference – more cancer
discharges required assistance with zero to one ADL’s and had little to no cognitive
impairment, whereas more non-cancer discharges needed help with three to five ADL’s
and displayed significantly less cognitive function. Along the same lines, adjusted odds
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showed that needing assistance with more than one ADL, as well as exhibiting cognitive
impairment at any level, led to decreased chances of a cancer diagnosis.
In addition to the majority of all discharges receiving hospice services for less
than three months, this study provided that those with non-cancer diagnoses more often
had greater length of stays, while those with cancer diagnoses were more often enrolled
for eight days to three months. Not only has evidence validated that most hospice
referrals occur too late in the dying process, but studies also show that the problem is
further compounded by the physician reimbursement incentives related to continuing
curative treatments, as often seen with cancer patients (Hoefler, 2010). In this study,
multivariate regression results indicated a significantly greater chance of a cancer
diagnosis for any length of stay less than 180 days; however, a length of stay of 29 days
or less held the highest predictive value.
Finally, assessing differences in symptoms between the two diagnosis groups,
pain and dyspnea were indicated more often for cancer patients, but no significant
difference existed for depression. Although another study comparing cancer and noncancer patients reported no significant difference in pain and a significantly greater
amount of non-cancer patients suffering from dyspnea, conflicting results may be
attributed to potential variance of specific cancer diagnoses included in each sample, as
some malignancies have the ability to cause more pain and symptoms than others (Given,
Given, Azzouz, Kozachik, & Stommel, 2001). In this sample, final adjusted odds
indicated that discharges with pain symptoms were significantly more likely to admit
with a cancer diagnosis. While regression revealed a non-significant relationship
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between hospice diagnosis and dyspnea symptoms, 95% confidence intervals came very
close to demonstrating a significantly protective association with cancer diagnosis.
When comparing this study to others that also focus on disparities and hospice
utilization, important strengths are evident. First, this analysis includes nationally
representative data, as provided by the CDC, National Center for Health Statistics. The
agencies surveyed were chosen systematically and randomly, with probability
proportional to size, from a sample frame of over 15,000 agencies across the U.S.
(“NHHCS - National Home and Hospice Care Survey,” n.d.). Although it is important to
take caution when referring to the results as generalizable, this study likely represents the
U.S. population to a greater degree than other studies in the literature utilizing data from
one specific hospice agency with multiple locations or vice-versa. Another strength lies
in the data and methods allowing for the control of confounders. Because of a multitude
of available variables in the data set, it was possible to analyze independent variables’
relationships to the dependent variable in light of several sociodemographic and clinical
characteristics.
While strong in some aspects, this study certainly poses its own limitations.
Perhaps most importantly, the analysis was based on cross-sectional survey data, making
it impossible to evaluate true “causality”. Since such data is gathered at only one point in
time, prevalence odds ratios only provide potential evidence of relationships or
associations between variables. Another limitation of this study relates to the use of the
listwise deletion method. Of the original 4,733 hospice cases included in the data set,
only 3,905 were used during final analysis, due to the fact that data was missing for key
variables. Although still a large sample size, the reduction in cases may have affected the
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significance of results through changes in statistical power. Other limitations involve the
inability to control for religion/spirituality and SES (income and education), both of
which have been shown to play a role in hospice utilization. Primary payer source was
used as proxy variable for income, as health care coverage has been directly linked with
poverty status; however, the substitution is far from a perfect choice (Collins, Robertson,
Garber, & Doty, 2012). Finally, although research has pinpointed links between
characteristics (e.g., size and location) of the agency providing care and hospice use and
diagnosis, controls for agency differences were not included in this analysis (Johnson et
al., 2007). Further research is needed to more comprehensively build a multivariate
regression model that better predicts patient characteristics’ relationships with diagnosis.
Overall, this study highlights important implications related to continuing
“business as usual” in the end-of-life health care field. Not only do results further
confirm statistics exposing the alarmingly low utilization of hospice services in general,
but they also validate diagnosis-specific differences in use and required care, seemingly
driven by both individual and population-based characteristics. In order to increase
utilization and access rates and eliminate current disparities, patients presenting with
certain terminal diseases may require greater provider flexibility in terms of hospice
eligibility requirements and services offered. Consequently, in addition to health
education promoting general awareness of hospice benefits, it is necessary to consider
addressing end-of-life care systematic and policy standards that may be strengthening
hospice use disparities, such as those emphasized in this analysis.
Some critics suggest moving from a prognosis-based eligibility system to one that
is needs based, for example, which may increase length of stay and allow for more
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comprehensive care for those that are not 100% ready to give up hope for their curative
treatment (Carlson, Morrison, & Bradley, 2008). Another suggestion that may impact a
reduction in hospice use disparities requires changes on the educational side of the U.S.
health care system. Research shows that although most medical and nursing schools
offer some training on end-of-life matters, the average student spends less than 15 hours
focused on the topic, and that only one-tenth of programs offer a complete palliative care
course. Furthermore, only about half of students spend time with a hospice patient
(Dickinson, 2007). Reconsidering medical education requirements may be an effective
way to encourage physician comfort concerning the topic of death, thereby potentially
increasing the likelihood that hospice services are addressed more frequently with
patients. While many possible reform options exist, each ignites its own, fueled debate
and requires additional research to determine feasibility from both cost and logistical
viewpoints.
In conclusion, this study revealed several important disparities related to the use
of hospice between cancer and non-cancer discharges. As determined through
multivariate logistic regression, the following factors were found significantly associated
with primary hospice diagnosis: age of 85+ at discharge, private insurance as a primary
payment source, deceased status upon discharge, hospice initiation at primary residence,
length of stay less than 180 days, requiring assistance with two to five ADL’s, level of
cognitive function, and presence of pain. Although not shown to be associated with
primary diagnosis in light of the final results, sex and White racial status came extremely
close to reaching significance. While additional research is required to more
meticulously describe relationships shaping cancer vs. non-cancer hospice disparities, the
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differences that emerged from this study offer further insight to aid in the fight against
end-of-life care inequalities in the U.S.
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Appendix
Statistical Summary Tables

Table 1. Distribution of Terminal Diseases, n = 3905
Terminal Disease

n

%

HIV/AIDS
Organic Psychotic Conditions
(including Dementia)
Nervous System
(including Parkinson’s, Multiple Sclerosis,
Muscular Dystrophy)
Circulatory System
(including Ischemic Heart Disease,
Heart Failure, Cerebrovascular Disease)
Respiratory System
(including Pulmonary Fibrosis, Chronic Airway
Obstruction)
Digestive System
(including Chronic liver disease, Cirrhosis)
Genitourinary System
(including Renal Failure, Chronic Kidney Disease)
Musculoskeletal System/Connective Tissue
(including Systemic Sclerosis, Bone Infections)
Other
(including Failure to Thrive, Debility Unspecified)

7
206

.2
5.3

234

6.0

614

15.7

304

7.8

72

1.8

112

2.9

6

.2

485

12.4

Total Non-Cancer

2040

52.2

Cancer

1865

47.8

!
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Table 2. Comparison of Sociodemographic Variables Between Discharges with Cancer vs. Noncancer Hospice Diagnoses
Variable

Sex
Male
Female
Age
18-34
35-64
65-74
75-84
85+
Hispanic/Latino
Race
White
Native Hawaiian/Pacific Islander
African American
Asian
American Indian/Alaska Native
Primary Payment Source
No Charge/Other
Self-pay
Private Insurance
Other Government
Medicaid
Medicare
Deceased

Non-Cancer
(n = 2040)

Cancer
(n = 1865)

812 (39.8%)
1228 (60.2%)

959 (51.4%)
906 (48.6%)

3 (.1%)
143 (7%)
265 (13%)
618 (30.3%)
1011 (49.6%)
52 (2.5%)

13 (.7%)
530 (28.4%)
400 (21.4%)
605 (32.4%)
317 (17%)
54 (2.9%)

1842 (90.3%)
6 (.3%)
154 (7.5%)
18 (.9%)
20 (1%)

1727 (92.6%)
2 (.1%)
108 (5.8%)
14 (.8%)
13 (.7%)

24 (1.2%)
9 (.4%)
42 (2.1%)
13 (.6%)
43 (2.1%)
1909 (93.6%)
1511 (74.1%)

50 (2.7%)
22 (1.2%)
284 (15.2%)
54 (2.9%)
114 (6.1%)
1341 (71.9%)
1641 (88%)

Difference
p
< .001

< .001

	
  

.506
.010
.293
.028
.648
.334
< .001

< .001
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Table 3. Comparison of Clinical Variables Between Discharges with Cancer vs. Non-cancer
Hospice Diagnoses
Variable

Location Hospice Initiated
Agency Inpatient/Residential Facility
Private Residence
Residential Care Facility
Nursing Home
Hospital
Other
Length of Stay in Days
180+
90-179
30-89
8-29
<7
Level of Care at Discharge
Routine Homecare
Continuous Homecare
GIP
Respite
Number of ADL’s Requiring Help
0
1
2
3
4
5
Cognitive Function at Admission
No Cognitive Impairment
Requires Occasional Reminders
Requires Situational Assistance
Requires Routine Assistance
Severe Cognitive Impairment
Dyspnea
Depression
Pain

Non-Cancer
(n = 2040)

Cancer
(n = 1865)

100 (4.9%)
1058 (51.9%)
164 (8%)
585 (28.7%)
120 (5.9%)
13 (.6%)

72 (3.9%)
1459 (78.2%)
37 (2%)
179 (9.6%)
105 (5.6%)
13 (.7%)

Difference
p
< .001

< .001
376 (18.4%)
235 (11.5%)
414 (20.3%)
485 (23.8%)
530 (26%)

120 (6.4%)
151 (8.1%)
450 (24.1%)
656 (35.2%)
488 (26.2%)

1668 (81.8%)
87 (4.3)
265 (13%)
20 (1%)

1508 (80.9%)
82 (4.4%)
258 (13.8%)
17 (.9%)

.872

< .001
109 (5.3%)
57 (2.8%)
198 (9.7%)
451 (22.1%)
649 (31.8%)
576 (28.2%)

277 (14.9%)
127 (6.8%)
184 (9.9%)
342 (18.3%)
520 (27.9%)
415 (22.3%)

410 (20.1%)
265 (13%)
342 (16.8%)
626 (30.7%)
397 (19.5%)
872 (42.7%)
181 (8.9%)
521 (25.5%)

880 (47.2%)
331 (17.7%)
303 (16.2%)
270 (14.5%)
81 (4.3%)
894 (47.9%)
138 (7.4%)
708 (38%)

< .001

!

	
  

.001
.093
< .001
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Table 4. Unadjusted Odds Ratios and 95% Confidence Intervals for Variables Predicting
Cancer Hospice Diagnosis (vs. Non-Cancer Hospice Diagnosis), n = 3905
Variable
Sex
Male
Female
Age
18-34
35-64
65-74
75-84
85+
Race
White
African American
Primary Payment Source
No Charge/Other
Self-pay
Private Insurance
Other Government
Medicaid
Medicare
Deceased
Location Hospice Initiated
Agency Inpatient/Residential Facility
Private Residence
Residential Care Facility
Nursing Home
Hospital
Other
Length of Stay in Days
180+
90-179
30-89
8-29
<7
Number of ADL’s Requiring Help
0
1
2
3
4
5
Cognitive Function at Admission
No Cognitive Impairment
Requires Occasional Reminders
Requires Situational Assistance
Requires Routine Assistance3
Severe Cognitive Impairment
Dyspnea
Pain

Odds Ratio

95% CI

1
0.625*

(0.550, 0.709)

1
0.855
0.348
0.226*
0.072*

(0.240, 3.042)
(0.098, 1.234)
(0.064, 0.797)
(0.020, 0.256)

1.345*
0.753*

(1.072, 1.688)
(0.584, 0.971)

1
1.173
3.246*
1.994
1.273
0.337*
2.565*

(0.470, 2.931)
(1.809, 5.824)
(0.917, 4.336)
(0.698, 2.319)
(0.206, 0.551)
(2.161, 3.044)

1
1.915*
0.313*
0.425*
1.215
1.389

(1.400, 2.619)
(0.196, 0.500)
(0.301, 0.601)
(0.814, 1.814)
(0.608, 3.173)

1
2.013*
3.406*
4.238*
2.885*

(1.507, 2.690)
(2.666, 4.351)
(3.345, 5.370)
(2.271, 3.666)

1
0.877
0.366*
0.298*
0.315*
0.284*

(0.598, 1.286)
(0.271, 0.493)
(0.230, 0.388)
(0.246, 0.405)
(0.220, 0.366)

1
0.582*
0.413*
0.201*
0.095*
1.233*
1.784*

(0.477, 0.711)
(0.340, 0.501)
(0.167, 0.242)
(0.073, 0.124)
(1.087, 1.399)
(1.556, 2.045)

!
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Table 5. Adjusted Odds Ratios and 95% Confidence Intervals for Variables Predicting
Cancer Hospice Diagnosis (vs. Non-Cancer Hospice Diagnosis), n = 3905
Variable
Sex
Male
Female
Age
18-34
35-64
65-74
75-84
85+
Race
White
African American
Primary Payment Source
No Charge/Other
Self-pay
Private Insurance
Other Government
Medicaid
Medicare
Deceased
Location Hospice Initiated
Agency Inpatient/Residential Facility
Private Residence
Residential Care Facility
Nursing Home
Hospital
Other
Length of Stay in Days
180+
90-179
30-89
8-29
<7
Number of ADL’s Requiring Help
0
1
2
3
4
5
Cognitive Function at Admission
No Cognitive Impairment
Requires Occasional Reminders
Requires Situational Assistance
Requires Routine Assistance
Severe Cognitive Impairment
Dyspnea
Pain

Odds Ratio

95% CI

1
0.920

(0.787, 1.074)

1
0.994
0.778
0.671
0.254*

(0.263, 3.764)
(0.203, 2.990)
(0.175, 2.574)
(0.066, 0.976)

1.664
1.273

(0.930, 2.975)
(0.667, 2.430)

1
1.161
2.458*
2.121
1.426
0.716
3.041*

(0.408, 3.309)
(1.268, 4.765)
(0.874, 5.148)
(0.718, 2.832)
(0.403, 1.272)
(2.440, 3.790)

1
1.806*
0.655
0.846
1.302
1.025

(1.243, 2.625)
(0.384, 1.118)
(0.564, 1.269)
(0.817, 2.074)
(0.375, 2.802)

1
1.622*
2.347*
3.043*
2.881*

(1.151, 2.286)
(1.755, 3.138)
(2.296, 4.033)
(2.147, 3.867)

1
0.972
0.541*
0.471*
0.499*
0.547*

(0.624, 1.513)
(0.376, 0.779)
(0.339, 0.655)
(0.365, 0.680)
(0.396, 0.755)

1
0.725*
0.569*
0.305*
0.148*
0.855
1.583*

(0.576, 0.912)
(0.454, 0.713)
(0.244, 0.381)
(0.108, 0.201)
(0.731, 1.002)
(1.338, 1.872)
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